Pfizer · 1 week ago
US Oncology Marketing Launch Lead, Mevrometostat
United States - Washington – Bothell
Full-time
Onsite
Senior Level
$177K/yr - $283K/yr
5+ years expPfizer is a leading pharmaceutical company focused on developing transformative therapies to combat cancer. They are seeking a US Oncology Marketing Launch Lead for the launch of Mevrometostat, responsible for driving the market introduction and ensuring robust launch readiness through strategic collaboration with cross-functional teams.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
No H1B
Responsibilities
Develop & execute the US go-to-market strategy and implementation plan in close collaboration with US Cross-Functional Team and Global Marketing
Lead the development of all US launch readiness frameworks defined by launch excellence
Develop KPIs for key tactics that will drive launch performance and optimization
Lead US marketing efforts in development of best-in-class HCP strategies, messaging, and tactics that strategically position Mevrometostat to win on behalf of patients, in a highly competitive market
Lead annual Operating Plan and LRF
Lead development and execution of US External Stakeholder Engagement, Congress, & Peer-to-Peer (P2P) strategy and implementation plan
Monitor competitive landscape and develop communications and action plans as needed
Manage various US vendor relationships, work processes, and expenses to meet business objectives
Provide oversight of Mevrometostat Review Committee
Conduct all activities and make decisions that are in accordance with Company policies, Pfizer values & global regulatory guidelines
Qualification
Required
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact
Bachelor's degree and 8+ years of pharmaceutical industry experience required, or Master's degree and 7+ years of experience, or Ph.D./PharmD and 5+ years of experience required
2+ years of Oncology HCP Marketing experience required
Demonstrated success developing and executing complex marketing programs, specifically leading a US launch
Proven track record of building and leading high-functioning teams to drive business performance
Solid business acumen and organizational skills with excellent interpersonal communication and negotiation skills for diverse audiences, including senior management
Strong analytical skills, ability to synthesize complex information and distill critical customer insights
Ability to translate strategy and analysis to a tactical, executable level to drive brand performance
Experience with product positioning and branding
Demonstrated ability to manage and deliver results on multiple, complex, competing projects in a deadline-oriented environment
Experience forecasting and leading the development of annual strategic plans
High-energy, proactive self-starter with the initiative to function autonomously and the confidence and ingenuity to initiate, create, and innovate
Role model for the Pfizer Values
Preferred
Prior US Launch experience
Prior US Oncology marketing experience
Knowledge of Prostate or GU Cancer
Benefits
Participation in Pfizer’s Global Performance Plan with a bonus target of 20.0% of the base salary
Eligibility to participate in our share based long term incentive program
401(k) plan with Pfizer Matching Contributions
An additional Pfizer Retirement Savings Contribution
Paid vacation
Holiday and personal days
Paid caregiver/parental and medical leave
Health benefits to include medical, prescription drug, dental and vision coverage
Company
Pfizer
Pfizer is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$38BKey Investors
Starboard Value
2025-11-21Post Ipo Debt· $6B
2024-10-07Post Ipo Equity· $1B
2023-05-16Post Ipo Debt· $31B
Leadership Team
Albert Bourla
Chief Executive Officer
Ian Read
Chief Executive Officer
Recent News
2026-01-22
Maryland Daily Record
2026-01-22
Company data provided by crunchbase